Earnings · China A-shares
Beijing Konruns Pharmaceutical Co., Ltd. Class A (603590) earnings
Beijing Konruns Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-29: net profit -21.96% year on year, -28.26% excluding one-off items. Wave Radar's earnings-quality score is 95 of 100 (Sound). The stock moved -7.54% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- -21.96%
- Excl. one-offs YoY
- -28.26%
- Net profit QoQ
- -91.59%
- Result
- Bad / loss
- Quality score
- 95
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -6.52% | — |
| 3 days | -7.54% | — |
| 7 days | -4.11% | — |
| 14 days | -11.87% | — |
Report history
Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 3 of 6 reports (average +3.77%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | ¥99.80M | -21.96% | -28.26% | -7.51% | 0.64 | 3.12% | -7.54% | — | — |
| 2026 interim report | 2026-08-26 | ¥95.72M | +5.14% | -4.23% | +0.42% | 0.61 | 2.98% | -0.32% | -9.17% | -2.18% |
| 2026 Q1 report | 2026-04-23 | ¥47.21M | +6.10% | +4.94% | +1.35% | 0.30 | 1.46% | -4.28% | -21.24% | -19.69% |
| 2025 annual report | 2026-04-23 | ¥165.97M | +293.13% | +420.51% | +10.87% | 1.05 | 5.23% | -4.28% | -21.24% | -19.69% |
| 2025 Q3 report | 2025-10-30 | ¥127.88M | +13.19% | +25.90% | +7.10% | 0.81 | 4.04% | +2.44% | -11.32% | -6.58% |
| 2025 interim report | 2025-08-28 | ¥91.05M | +14.95% | +29.21% | +13.79% | 0.58 | 2.87% | +24.85% | +1.68% | -3.82% |
| 2025 Q1 report | 2025-04-26 | ¥44.50M | +6.83% | +10.70% | +6.41% | 0.28 | 1.41% | +7.46% | +18.33% | +15.08% |
| 2024 annual report | 2025-04-26 | ¥42.22M | -71.94% | -75.52% | -10.28% | 0.27 | 1.36% | +7.46% | +18.33% | +15.08% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.